DrugPatentWatch Database Preview
Cytarabine - Generic Drug Details
What are the generic drug sources for cytarabine and what is the scope of cytarabine patent protection?
Cytarabine
is the generic ingredient in four branded drugs marketed by Pacira Pharms Inc, Fresenius Kabi Usa, Hong Kong, Hospira, Mylan Labs Ltd, Teva Parenteral, West-ward Pharms Int, Teva Pharms Usa, and Celator Pharms, and is included in eighteen NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are fifteen drug master file entries for cytarabine. Four suppliers are listed for this compound.
Summary for cytarabine
| US Patents: | 7 |
| Tradenames: | 4 |
| Applicants: | 9 |
| NDAs: | 18 |
| Drug Master File Entries: | 15 |
| Suppliers / Packagers: | 4 |
| Bulk Api Vendors: | 93 |
| Clinical Trials: | 985 |
| Patent Applications: | 7,475 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for cytarabine |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for cytarabine |
| DailyMed Link: | cytarabine at DailyMed |
Pharmacology for cytarabine
| Drug Class | Nucleoside Metabolic Inhibitor |
| Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for cytarabine
Synonyms for cytarabine
| (beta-D-Arabinofuranosyl)cytosine |
| (non-labelled)Cytarabine-13C-15N2 |
| 04079A1RDZ |
| 1-.beta.-D-arabinofuranosyl-cytosine |
| 1-(arabinofuranosyl)cytosine |
| 1-(b-D-Arabinofuranosyl)cytosine |
| 1-Arabinofuranosylcytosine |
| 1-beta -D-Arabinofaranosylcytosine |
| 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone |
| 1-beta -d-arabinofuranosylcytosine |
| 1-beta-arabinofuranosylcytosine |
| 1-beta-D-Arabinofaranosylcytosine |
| 1-beta-D-arabinofuranosyl cytosine |
| 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone |
| 1-beta-D-arabinofuranosyl-cytosine |
| 1-beta-D-Arabinofuranosylcytosine |
| 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside |
| 1-beta-D-Arabinosyl-Cytosine |
| 1-beta-D-Arabinosylcytosine |
| 10163-EP2272828A1 |
| 10163-EP2284920A1 |
| 10163-EP2287165A2 |
| 10163-EP2287166A2 |
| 10163-EP2292603A1 |
| 10163-EP2292620A2 |
| 10163-EP2298764A1 |
| 10163-EP2298765A1 |
| 10163-EP2298774A1 |
| 10163-EP2299509A1 |
| 10163-EP2301921A1 |
| 10163-EP2301926A1 |
| 10163-EP2301936A1 |
| 10163-EP2308843A1 |
| 10163-EP2314558A1 |
| 10163-EP2316452A1 |
| 10163-EP2371810A1 |
| 10163-EP2372804A1 |
| 10163-EP2378585A1 |
| 147-94-4 |
| 147C944 |
| 15153-EP2270018A1 |
| 15153-EP2272832A1 |
| 15153-EP2275420A1 |
| 15153-EP2277565A2 |
| 15153-EP2277566A2 |
| 15153-EP2277567A1 |
| 15153-EP2277568A2 |
| 15153-EP2277569A2 |
| 15153-EP2277570A2 |
| 15153-EP2277865A1 |
| 15153-EP2292280A1 |
| 15153-EP2295055A2 |
| 15153-EP2295416A2 |
| 15153-EP2295426A1 |
| 15153-EP2295427A1 |
| 15153-EP2298748A2 |
| 15153-EP2298764A1 |
| 15153-EP2298765A1 |
| 15153-EP2298768A1 |
| 15153-EP2298778A1 |
| 15153-EP2298780A1 |
| 15153-EP2301928A1 |
| 15153-EP2305642A2 |
| 15153-EP2305689A1 |
| 15153-EP2308833A2 |
| 15153-EP2308855A1 |
| 15153-EP2308861A1 |
| 15153-EP2311453A1 |
| 15153-EP2311808A1 |
| 15153-EP2311825A1 |
| 15153-EP2311829A1 |
| 15153-EP2311840A1 |
| 15153-EP2311842A2 |
| 15153-EP2314590A1 |
| 15153-EP2316832A1 |
| 15153-EP2316833A1 |
| 15187-EP2270008A1 |
| 15187-EP2280012A2 |
| 15187-EP2281815A1 |
| 15187-EP2292233A2 |
| 15187-EP2292615A1 |
| 15187-EP2292617A1 |
| 15187-EP2301928A1 |
| 15187-EP2301933A1 |
| 15187-EP2305640A2 |
| 15187-EP2305671A1 |
| 15187-EP2308833A2 |
| 15187-EP2311827A1 |
| 15187-EP2311840A1 |
| 15187-EP2316832A1 |
| 15187-EP2316833A1 |
| 1beta -Arabinofuranasylcytosine |
| 1beta -D-Arabinofuranosylcytosine |
| 1beta -D-Arabinosylcytosine |
| 1beta-Arabinofuranasylcytosine |
| 1beta-D-Arabinofuranosylcytosine |
| 1beta-D-Arabinosylcytosine |
| 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl |
| 2(1H)-Pyrimidinone, 4-amino-1-.beta.-D-arabinofuranosyl- |
| 2(1H)-Pyrimidinone, 4-amino-1-|A-D-arabinofuranosyl- |
| 2(1H)-Pyrimidinone, 4-amino-1-beta -D-arabinofuranosyl- |
| 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl- |
| 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS] |
| 2(1H)-Pyrimidinone, 4-amino-1-y-D-arabinofuranosyl- [CAS] |
| 2(1H)-Pyrimidinone, 4-amino-1beta -D-arabinofuranosyl- |
| 4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one |
| 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one |
| 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
| 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one |
| 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin |
| 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech] |
| 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine |
| 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone |
| 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon |
| 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech] |
| 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone |
| 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one |
| 69-74-9 (hydrochloride) |
| AB0005212 |
| AC-1075 |
| AC1L1M4F |
| AC1Q52OJ |
| AI3-52329 |
| AJ-45634 |
| AK-54744 |
| AKOS007930145 |
| AKOS015896896 |
| Alexan |
| AM84428 |
| ANW-58969 |
| AR3 |
| Ara-C |
| Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine |
| Ara-Cytidine |
| Arabinocytidine |
| arabinocytosine |
| Arabinofuranosylcytosine |
| Arabinoside C |
| Arabinosyl Cytosine |
| Arabinosylcytosine |
| Arabitin |
| AraC |
| Aracytidine |
| Aracytin |
| Aracytine |
| Arafcyt |
| AX8008499 |
| BDBM50087289 |
| beta -arabinosylcytosine |
| beta -cytosine arabinoside |
| beta -D-arabinosylcytosine |
| beta-Ara C |
| beta-Arabinosylcytosine |
| Beta-cytosine arabinoside |
| beta-D-Arabinosylcytosine |
| BIDD:GT0371 |
| BIDD:PXR0139 |
| BRD-K33106058-001-07-7 |
| BRD-K33106058-003-20-6 |
| BTB15125 |
| C-55053 |
| C02961 |
| C9H13N3O5 |
| CAS-147-94-4 |
| CCG-51297 |
| CCRIS 913 |
| CHEBI:28680 |
| CHEMBL803 |
| CHX 3311 |
| Citarabina |
| Citarabina [INN-Spanish] |
| CPD000449317 |
| CS-2177 |
| CTK8B7927 |
| Cyclocide |
| Cytarabin |
| Cytarabina |
| Cytarabine (JP15/USP/INN) |
| Cytarabine (JP17/USP/INN) |
| CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9) |
| Cytarabine [USAN:INN:BAN:JAN] |
| Cytarabine [USAN:USP:INN:BAN:JAN] |
| cytarabine liposome |
| cytarabine liposome injection |
| Cytarabine, European Pharmacopoeia (EP) Reference Standard |
| Cytarabine, United States Pharmacopeia (USP) Reference Standard |
| Cytarabine; 2(1H)-Pyrimidinone,4-amino-1-a-Darabinofuranosyl- |
| Cytarabinoside |
| Cytarabinum |
| Cytarabinum [INN-Latin] |
| Cytarbel |
| Cytartbine |
| Cytonal |
| Cytosar |
| Cytosar-U |
| Cytosar-U (TN) |
| Cytosine 1-beta-D-arabinofuranoside |
| Cytosine arabinofuranoside |
| Cytosine arabinose |
| Cytosine arabinoside |
| Cytosine arabinoside (VAN) |
| Cytosine beta-D-arabinofuranoside |
| Cytosine beta-D-arabinofuranoside hydrochloride |
| Cytosine beta-D-arabinofuranoside, crystalline, >=90% (HPLC) |
| Cytosine beta-D-arabinofuranoside, Vetec(TM) reagent grade, 90% |
| Cytosine beta-D-arabinoside |
| Cytosine-1-beta-D-arabinofuranoside |
| Cytosine-beta -arabinoside |
| Cytosine-beta -D-arabinofuranoside |
| Cytosine-beta-arabinoside |
| Cytosine-beta-D-arabinofuranoside |
| Cytosine, 1-beta -D-arabinofuranosyl- |
| Cytosine, 1-beta -D-arabinosyl- |
| Cytosine, 1-beta-D-arabinofuranosyl- |
| Cytosine, 1-beta-D-arabinosyl- |
| Cytosine, beta -D-arabinoside |
| Cytosine, beta-D-arabinoside |
| Cytosinearabinoside |
| D00168 |
| D07XSN |
| DB00987 |
| Depocyt |
| Depocyt (liposomal) |
| Depocyt (TN) |
| DepoCyte |
| DSSTox_CID_2877 |
| DSSTox_GSID_22877 |
| DSSTox_RID_76771 |
| DTXSID3022877 |
| EBD145460 |
| EINECS 205-705-9 |
| Erpalfa |
| FT-0082880 |
| FT-0624314 |
| GP6403 |
| GTPL4827 |
| HE003564 |
| HMS2051K19 |
| HMS2090A18 |
| HMS2230M16 |
| HSDB 3049 |
| HY-13605 |
| Intrathecal (injected into the spinal fluid) DepoCyt |
| Intrathecal cytarabine (also known as ara-C) |
| Iretin |
| J-520199 |
| J-700005 |
| J-700166 |
| J10463 |
| K-4708 |
| KB-09511 |
| KS-0000022L |
| KS-5063 |
| KSC917S2P |
| Lopac0_000316 |
| LS-860 |
| MCULE-3945147956 |
| MFCD00066487 |
| MK 8242 |
| MLS000758310 |
| MLS001066340 |
| MLS001424023 |
| MolPort-001-792-509 |
| NC00070 |
| NCGC00093356-03 |
| NCGC00093356-04 |
| NCGC00093356-05 |
| NCGC00093356-06 |
| NCGC00142483-02 |
| NCGC00255381-01 |
| NCI-C04728 |
| NSC 287459 |
| NSC287459 |
| NU006827 |
| PubChem14152 |
| PYR287 |
| RL01868 |
| s1648 |
| SAM001247012 |
| SCHEMBL3140 |
| SL-000002 |
| SMR000449317 |
| Spongocytidine |
| SR-01000075773-3 |
| SRI-10828_24 |
| SRI-10828-19 |
| SRI-10828-20 |
| ST24043183 |
| SY004943 |
| Tarabine |
| TL8001048 |
| Tox21_111203 |
| Tox21_301971 |
| TR-008148 |
| U 19920A |
| U-19,920 |
| U-19920 |
| Udicil |
| UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
| UNII-04079A1RDZ |
| Z1522566619 |
| ZINC3795098 |
US Patents and Regulatory Information for cytarabine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Celator Pharms | VYXEOS | cytarabine; daunorubicin | POWDER;INTRAVENOUS | 209401-001 | Aug 3, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| West-ward Pharms Int | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 071472-001 | Aug 2, 1989 | RX | No | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Hong Kong | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 205696-001 | Jul 17, 2018 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for cytarabine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pacira Pharms Inc | DEPOCYT | cytarabine | INJECTABLE, LIPOSOMAL;INJECTION | 021041-001 | Apr 1, 1999 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Pacira Pharms Inc | DEPOCYT | cytarabine | INJECTABLE, LIPOSOMAL;INJECTION | 021041-001 | Apr 1, 1999 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-002 | Approved Prior to Jan 1, 1982 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: